Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
33213 | 128 | 27.2 | 31% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
350 | 3 | COMPLEMENT//MANNOSE BINDING LECTIN//IMMUNOLOGY | 35656 |
2797 | 2 | FC RECEPTOR//FC GAMMA RECEPTORS//FC GAMMA RECEPTOR | 3097 |
33213 | 1 | PLANT MITOGENS//PHA L4//MITOGENIC LECTINS | 128 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | PLANT MITOGENS | authKW | 954237 | 3% | 100% | 4 |
2 | PHA L4 | authKW | 477118 | 2% | 100% | 2 |
3 | MITOGENIC LECTINS | authKW | 429404 | 2% | 60% | 3 |
4 | ADOPTIVE LEUKOCYTE THERAPY | authKW | 238559 | 1% | 100% | 1 |
5 | ANTIBACTERIAL VACCINES | authKW | 238559 | 1% | 100% | 1 |
6 | APLASTIC ANEMIAS | authKW | 238559 | 1% | 100% | 1 |
7 | AUGMENTED MYELOPROLIFERATION | authKW | 238559 | 1% | 100% | 1 |
8 | BIOLOGICAL WARFARE TERRORIST ATTACKS | authKW | 238559 | 1% | 100% | 1 |
9 | EFFECTIVE TREATMENT OF INFECTIONS | authKW | 238559 | 1% | 100% | 1 |
10 | FRACTION IV | authKW | 238559 | 1% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Immunology | 1313 | 48% | 0% | 62 |
2 | Transplantation | 287 | 10% | 0% | 13 |
3 | Oncology | 155 | 20% | 0% | 25 |
4 | Medicine, Research & Experimental | 91 | 11% | 0% | 14 |
5 | Pharmacology & Pharmacy | 68 | 16% | 0% | 20 |
6 | Medicine, General & Internal | 63 | 12% | 0% | 15 |
7 | Medical Laboratory Technology | 63 | 4% | 0% | 5 |
8 | Radiology, Nuclear Medicine & Medical Imaging | 58 | 9% | 0% | 12 |
9 | Surgery | 57 | 13% | 0% | 17 |
10 | Cell Biology | 27 | 9% | 0% | 12 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MED MED ROGOSIN BIOCHEM | 238559 | 1% | 100% | 1 |
2 | BACTERIAL MYCOT DIS C09 | 119279 | 1% | 50% | 1 |
3 | PRECLIN FORENS SCI | 79518 | 1% | 33% | 1 |
4 | MED PATHOL PHYSIOL | 59638 | 1% | 25% | 1 |
5 | LARGO AGOSTINO GEMELLI 8 | 47710 | 1% | 20% | 1 |
6 | DIPARTIMENTO ONCOL NEUROSCI | 4586 | 1% | 2% | 1 |
7 | DIPARTIMENTO MED SCI INVECCHIAMENTO | 1938 | 1% | 1% | 1 |
8 | MED MED BIOCHEM | 1862 | 1% | 1% | 1 |
9 | MED MED MED | 1498 | 1% | 1% | 1 |
10 | THER EUT CHEM | 1401 | 1% | 1% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS | 23554 | 9% | 1% | 12 |
2 | VESTNIK AKADEMII MEDITSINSKIKH NAUK SSSR | 20392 | 9% | 1% | 11 |
3 | JOURNAL OF CLINICAL & LABORATORY IMMUNOLOGY | 5363 | 4% | 0% | 5 |
4 | ACTA MEDICA ACADEMIAE SCIENTIARUM HUNGARICAE | 2943 | 1% | 1% | 1 |
5 | FOLIA BIOLOGICA | 2701 | 3% | 0% | 4 |
6 | CELLULAR IMMUNOLOGY | 2473 | 7% | 0% | 9 |
7 | VOPROSY ONKOLOGII | 2451 | 3% | 0% | 4 |
8 | REVUE ROUMAINE DE MEDECINE-MEDECINE INTERNE | 2314 | 1% | 1% | 1 |
9 | SURVEY OF IMMUNOLOGIC RESEARCH | 1393 | 1% | 1% | 1 |
10 | ACTA MEDICA HUNGARICA | 1281 | 1% | 1% | 1 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PLANT MITOGENS | 954237 | 3% | 100% | 4 | Search PLANT+MITOGENS | Search PLANT+MITOGENS |
2 | PHA L4 | 477118 | 2% | 100% | 2 | Search PHA+L4 | Search PHA+L4 |
3 | MITOGENIC LECTINS | 429404 | 2% | 60% | 3 | Search MITOGENIC+LECTINS | Search MITOGENIC+LECTINS |
4 | ADOPTIVE LEUKOCYTE THERAPY | 238559 | 1% | 100% | 1 | Search ADOPTIVE+LEUKOCYTE+THERAPY | Search ADOPTIVE+LEUKOCYTE+THERAPY |
5 | ANTIBACTERIAL VACCINES | 238559 | 1% | 100% | 1 | Search ANTIBACTERIAL+VACCINES | Search ANTIBACTERIAL+VACCINES |
6 | APLASTIC ANEMIAS | 238559 | 1% | 100% | 1 | Search APLASTIC+ANEMIAS | Search APLASTIC+ANEMIAS |
7 | AUGMENTED MYELOPROLIFERATION | 238559 | 1% | 100% | 1 | Search AUGMENTED+MYELOPROLIFERATION | Search AUGMENTED+MYELOPROLIFERATION |
8 | BIOLOGICAL WARFARE TERRORIST ATTACKS | 238559 | 1% | 100% | 1 | Search BIOLOGICAL+WARFARE+TERRORIST+ATTACKS | Search BIOLOGICAL+WARFARE+TERRORIST+ATTACKS |
9 | EFFECTIVE TREATMENT OF INFECTIONS | 238559 | 1% | 100% | 1 | Search EFFECTIVE+TREATMENT+OF+INFECTIONS | Search EFFECTIVE+TREATMENT+OF+INFECTIONS |
10 | FRACTION IV | 238559 | 1% | 100% | 1 | Search FRACTION+IV | Search FRACTION+IV |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | WIMER, BM , MANN, PL , (2002) MITOGEN INFORMATION SUMMARIES.CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS. VOL. 17. ISSUE 5. P. 569-597 | 11 | 38% | 9 |
2 | WIMER, BM , MANN, PL , (2000) MITOGEN IMMUNOTHERAPY FOR HIV INFECTIONS EXEMPLIFIED BY PHYTOHEMAGGLUTININ AND POKEWEED MITOGEN.CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS. VOL. 15. ISSUE 6. P. 629-644 | 8 | 42% | 1 |
3 | WIMER, BM , (2003) CURATIVE POTENTIAL OF FOREMOST MITOGEN APPLICATIONS.CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS. VOL. 18. ISSUE 6. P. 903-916 | 3 | 100% | 6 |
4 | WIMER, BM , (2002) MITOGEN THERAPY FOR BIOLOGICAL WARFARE/TERRORIST ATTACKS AND VIRAL HEMORRHAGIC FEVER CONTROL.CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS. VOL. 17. ISSUE 1. P. 19-28 | 6 | 50% | 0 |
5 | VASILYEV, PS , (1988) CURRENT STATUS OF PARENTERAL-FEEDING AND OBJECTIVES OF ITS FURTHER DEVELOPMENT.VESTNIK AKADEMII MEDITSINSKIKH NAUK SSSR. VOL. . ISSUE 9. P. 44-49 | 4 | 100% | 0 |
6 | WIMER, BM , (1998) IMMUNOSUPPRESSIVE APPLICATIONS OF PHA AND OTHER PLANT MITOGENS.CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS. VOL. 13. ISSUE 2. P. 99 -107 | 5 | 50% | 8 |
7 | HILGERT, I , KRISTOFOVA, H , KREN, V , PANCZAK, A , (1984) THE EFFECT OF LENTIL LECTIN TREATMENT ON THE SURVIVAL OF RAT SKIN ALLOGRAFTS IN STRAIN COMBINATIONS WITH DIFFERENT GENETIC DISPARITY.FOLIA BIOLOGICA. VOL. 30. ISSUE 2. P. 104-108 | 5 | 100% | 1 |
8 | WIMER, BM , (2002) MITOGENS FOR CURATIVE THERAPY OF HIV-1 INFECTIONS; AN UPDATE.CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS. VOL. 17. ISSUE 2. P. 175-182 | 5 | 42% | 0 |
9 | WIMER, BM , (1998) PHA FOR APLASTIC ANEMIAS: THE ALPHA BUT NOT THE OMEGA OF MITOGEN THERAPIES.CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS. VOL. 13. ISSUE 2. P. 109 -120 | 5 | 45% | 2 |
10 | PERL, A , GONZALEZCABELLO, R , NEKAM, K , GERGELY, P , FEHER, J , (1985) STIMULATION BY THYMOPOIETIN OLIGOPEPTIDES OF LECTIN-DEPENDENT CELL-MEDIATED CYTOTOXICITY IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS.JOURNAL OF CLINICAL & LABORATORY IMMUNOLOGY. VOL. 18. ISSUE 3. P. 119-122 | 5 | 71% | 0 |
Classes with closest relation at Level 1 |